Vice President of Quality Assurance
Maureen is responsible for developing and maintaining Vascular Therapies’ Quality Systems and ensuring compliance with domestic and international GMPs and ISO directives and guidelines.
Trained as a scientist, Maureen is an expert in the areas of quality assurance, GMP auditing, compliance and liquid/parenteral formulation development. She has held leadership roles in globally respected pharmaceutical and biopharmaceutical research companies, including Pfizer, Wyeth and Agouron Pharmaceuticals.
Prior to joining Vascular Therapies, Maureen was Director of Pharmaceutical Sciences Quality Assurance, Quality Systems and Compliance at Pfizer, where she authored, trained and maintained the company’s Pharmaceutical Sciences Quality Plan and was responsible for the oversight and operation of its Governance Model.
Maureen holds several U.S. patents, including liquid and parenteral formulations of Sirolimus. She earned her B.S. in Biochemical Science from the University of Vermont.